Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors

Clinical trial NCT00003478 · COMPLETED

Trial details

NCT number: NCT00003478
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 1997-10-01
Primary completion: 2007-07-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.